Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial

Toon andere (1) versies

<strong>Background</strong> In Papua (Indonesia), infants with P. falciparum and/or P. vivax malaria are at risk of severe anaemia and death. We hypothesized that in an area of high malaria transmission, intermittent screening and treatment of infants with malaria (ISTi) will reduce morb...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Poespoprodjo, JR, Hafiidhaturrahmah, Sariyanti, N, Indrawanti, R, McLean, ARD, Simpson, JA, Kenangalem, E, Burdam, FH, Noviyanti, R, Trianty, L, Fadhilah, C, Soenarto, Y, Price, RN
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	BioMed Central 2022

Gelijkaardige items

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: A cluster randomised superiority trial
door: Poespoprodjo, Jeanne Rini, et al.
Gepubliceerd in: (2022)

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
door: Jeanne Rini Poespoprodjo, et al.
Gepubliceerd in: (2022-06-01)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2021)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
door: Rahmalia, A, et al.
Gepubliceerd in: (2019)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.
door: Burdam, F, et al.
Gepubliceerd in: (2016)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
door: Kenangalem, E, et al.
Gepubliceerd in: (2019)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
door: Pava, Z, et al.
Gepubliceerd in: (2017)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
door: Pava, Z, et al.
Gepubliceerd in: (2016)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
door: Pava, Z, et al.
Gepubliceerd in: (2020)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
door: Rahmalia, A, et al.
Gepubliceerd in: (2023)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.
door: Faustina Helena Burdam, et al.
Gepubliceerd in: (2016-01-01)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
door: Douglas, NM, et al.
Gepubliceerd in: (2017)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections.
door: Zuleima Pava, et al.
Gepubliceerd in: (2017-01-01)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a rising burden of Plasmodium vivax malaria
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2019)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia.
door: Zuleima Pava, et al.
Gepubliceerd in: (2016-01-01)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
door: Dini, S, et al.
Gepubliceerd in: (2020)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
door: Thriemer, K, et al.
Gepubliceerd in: (2020)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
door: Kho, S, et al.
Gepubliceerd in: (2018)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
door: Douglas, NM, et al.
Gepubliceerd in: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
door: Setyadi, A, et al.
Gepubliceerd in: (2019)

Early and late mortality after malaria in young children in Papua, Indonesia
door: Patriani, D, et al.
Gepubliceerd in: (2019)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
door: Devine, A, et al.
Gepubliceerd in: (2017)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia.
door: Zuleima Pava, et al.
Gepubliceerd in: (2020-05-01)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.
door: Enny Kenangalem, et al.
Gepubliceerd in: (2019-05-01)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
door: Poespoprodjo, Jeanne Rini, et al.
Gepubliceerd in: (2022)

Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
door: Lampah, D, et al.
Gepubliceerd in: (2015)

Passively versus actively detected malaria: similar genetic diversity but different complexity of infection
door: Pava, Z, et al.
Gepubliceerd in: (2017)

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.
door: Douglas, N, et al.
Gepubliceerd in: (2013)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2018)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
door: Annisa Rahmalia, et al.
Gepubliceerd in: (2023-05-01)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
door: Kho, S, et al.
Gepubliceerd in: (2016)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
door: Karyana, M, et al.
Gepubliceerd in: (2016)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
door: Kamala Thriemer, et al.
Gepubliceerd in: (2020-11-01)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
door: Marfurt, J, et al.
Gepubliceerd in: (2021)

Barriers to the success of COVID-19 immunisation programs in New Ireland Province, Papua New Guinea
door: Belinda Flanagan, et al.
Gepubliceerd in: (2023-09-01)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
door: Agus Setyadi, et al.
Gepubliceerd in: (2019-04-01)

Severe malarial thrombocytopenia : a risk factor for mortality in Papua, Indonesia
door: Lampah, Daniel A., et al.
Gepubliceerd in: (2015)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study.
door: Nicholas M Douglas, et al.
Gepubliceerd in: (2020-01-01)

Early and late mortality after malaria in young children in Papua, Indonesia
door: Dewi Patriani, et al.
Gepubliceerd in: (2019-10-01)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
door: Leonardo, L, et al.
Gepubliceerd in: (2022)